STEROID-HORMONE RECEPTOR ACTIVITY OF PRIMARY HUMAN BREAST-CANCER AND PATTERN OF 1ST METASTASIS

被引:72
作者
KOENDERS, PG
BEEX, LVAM
LANGENS, R
KLOPPENBORG, PWC
SMALS, AGH
BENRAAD, TJ
机构
[1] UNIV HOSP NIJMEGEN,DEPT MED,DIV ENDOCRINOL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS
[2] UNIV HOSP NIJMEGEN,DEPT EXPTL & CHEM ENDOCRINOL,6500 HB NIJMEGEN,NETHERLANDS
[3] UNIV HOSP NIJMEGEN,DEPT SURG,NIJMEGEN,NETHERLANDS
[4] UNIV HOSP NIJMEGEN,DEPT RADIOTHERAPY,NIJMEGEN,NETHERLANDS
[5] UNIV HOSP NIJMEGEN,DEPT PATHOL,NIJMEGEN,NETHERLANDS
[6] UNIV HOSP NIJMEGEN,DEPT RADIOL,NIJMEGEN,NETHERLANDS
[7] UNIV HOSP NIJMEGEN,DEPT MED ONCOL,NIJMEGEN,NETHERLANDS
关键词
ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; BREAST CANCER; METASTASIS PATTERNS;
D O I
10.1007/BF01975440
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A series of 258 breast cancer patients with known estrogen receptor (ER) status of the primary tumour who subsequently developed metastases were reviewed for site of first metastasis. In 188 cases progesterone receptor (PgR) data were also available. Univariate analysis showed metastatic patterns to differ statistically significantly related to ER status and (less pronounced) PgR status of the primary tumour. Patients with ER-positive tumours had bone metastases three times more often than patients with ER-negative tumours. With respect to PgR-positive and PgR-negative tumours this frequency differed by a factor of two. With regard to visceral metastases ER and PgR status were equally potent prognosticators, patients with receptor negative tumours having a 50% higher frequency of visceral metastasis than patients with receptor positive tumours. Assessment of metastatic patterns in relation to combined receptor status did not substantially enhance the discriminatory value of ER and PgR when assessed separately. Multivariate analysis showed that the observed differences in metastatic patterns were all attributable to differences in the ER status of the primary tumour, and were not influenced by age, menopausal status, axillary lymph node involvement, duration of disease-free interval (DFI), mode of postoperative treatment, or the PgR status of the primary tumour.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 17 条
  • [1] ALONKO A, 1985, CANCER, V56, P1696
  • [2] ESTROGEN-RECEPTOR STATUS AND SITES OF METASTASIS IN BREAST-CANCER
    CAMPBELL, FC
    BLAMEY, RW
    ELSTON, CW
    NICHOLSON, RI
    GRIFFITHS, K
    HAYBITTLE, JL
    [J]. BRITISH JOURNAL OF CANCER, 1981, 44 (03) : 456 - 459
  • [3] SURVIVAL FROM 1ST RECURRENCE - RELATIVE IMPORTANCE OF PROGNOSTIC FACTORS IN 1,015 BREAST-CANCER PATIENTS
    CLARK, GM
    SLEDGE, GW
    OSBORNE, CK
    MCGUIRE, WL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (01) : 55 - 61
  • [4] HAHNEL R, 1979, CANCER, V44, P671, DOI 10.1002/1097-0142(197908)44:2<671::AID-CNCR2820440238>3.0.CO
  • [5] 2-V
  • [6] KAMBY C, 1989, BRIT J CANCER, V60, P253
  • [7] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [8] QUAZI R, 1984, ARCH INTERN MED, V144, P2365
  • [9] ESTROGEN-RECEPTOR AND NATURAL COURSE OF BREAST-CANCER
    SINGHAKOWINTA, A
    POTTER, HG
    BUROKER, TR
    SAMAL, B
    BROOKS, SC
    VAITKEVICIUS, VK
    [J]. ANNALS OF SURGERY, 1976, 183 (01) : 84 - 88
  • [10] ESTROGEN-RECEPTORS, SITES OF METASTATIC DISEASE AND SURVIVAL IN RECURRENT BREAST-CANCER
    STEWART, JF
    KING, RJB
    SEXTON, SA
    MILLIS, RR
    RUBENS, RD
    HAYWARD, JL
    [J]. EUROPEAN JOURNAL OF CANCER, 1981, 17 (04) : 449 - 453